Lapatinib-d7 Ditosylate |
|
Synonyms: N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl-d7]amino]methyl]-2-furanyl]-4-quinazolinamine Bis(4-methylbenzenesulfonate) Ditosylate; GW-572016F-d7 Ditosylate; Tykerb-d7 Ditosylate; | |
Cat. No.: L12531 | CAS No.: 1009307-24-7/ 231277-92-2 (unlabelled) |
MDL.: | Formula: C43H35D7ClFN4O10S3 |
F.W.932.5 | Purity: 99% |
Storage: No Data Available | |
  |
Size/Unit | Price | Qty | Availability | Price Total |
---|---|---|---|---|
1mg | POA | Enter qty and click checkbox |
Catalog Number: | L12531 | CAS No.: | 1009307-24-7/ 231277-92-2 (unlabelled) | |
MDL: | Formula: | C43H35D7ClFN4O10S3 | ||
F.W.: | 932.5 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | No Data Available | M.P.: | No Data Available | |
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | No Data Available | Stability: | ||
Storage: | No Data Available | Category: | Reference Standard | |
Reference: | Kim, T.E., et al.: Drugs, 6, 886 (2003), Wood, E.R., et al.: Cancer Res., 64, 6652 (2004), Spector, N.L., et al.: J. Clin. Oncol., 23, 2502 (2005), | |||
Application: | Labelled Lapatinib (L175800). Reversible dual inhibitor of ErbB1 and ErbB2 tyrosine kinases. Antineoplastic. | |||
Category: | Isotope Labelled Compounds, Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals, Tyrosine Kinase Inhibitors, |